Tuesday, 17 June 2025 | 10:30 - 12:30
2.2 Parallel session: Neglected infectious diseases
Presentations:
OA-748 - Assessing the sensitivity of contact tracing for leprosy transmission links using VNTR typing in the Comoros
Bouke de Jong, Institute of Tropical Medicine (ITM), Belgium
OA-456 - Large-scale field application of rapid test for Mycobacterium leprae infection in the Comoros and Madagascar: effects of the PEOPLE trial on transmission in the population
Annemieke Geluk, Leiden University Medical Center (LUMC), Netherlands
OA-822 - Comparative efficacy of praziquantel and artemether-lumefantrine in the treatment of urinary and intestinal schistosomiasis among children in endemic community of Nigeria
Samuel Adedokun, Osun State University, Nigeria
OA-032 - Leveraging SMC platform for integrated co-delivery of albendazole and praziquantel in West African children: a mixed methods study of randomised controlled trial and qualitative research
Muhammed Afolabi, London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
OA-482 - Expanding mass drug administration for onchocerciasis in Central Africa: how diagnostic limitations could jeopardize elimination goals
André Domche, University of Yaoundé I, Cameroon
OA-175 - Improving the diagnosis of visceral leishmaniasis in Ethiopia
Henk Schallig, Amsterdam University Medical Center, Netherlands
OA-865 – The development and validation of a coformulation of albendazole/ivermectin to aid in the control of soil-transmitted helminthiasis. A tool for disease control and integration
Alejandro Krolewiecki, Mundo Sano Foundation, Spain